Drug shortage
Podofilox Topical Gel · AbbVie Inc.
FDA drug shortage · To Be Discontinued · updated Jan 28, 2026
Key facts
| Generic name | Podofilox Topical Gel |
|---|---|
| Company | AbbVie Inc. |
| Presentation | Condylox , Topical Gel, 0.5% (NDC 0023-6118-03) |
| Dosage form | Topical Gel |
| Status | To Be Discontinued |
| Therapeutic category | Dermatology Other |
| Package NDCs | 0023-6118-03 |
| First posted | Jan 28, 2026 |
| Last updated | Jan 28, 2026 |
| Discontinued | Jan 28, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: